Post-market surveillanceAndrogen Modulator
Compound 61437
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061437
Risk Class
MODERATE
Last Audit
Feb 8, 2108
Research Abstract
Androgen Modulator candidate engineered for endocrine support initiatives with automated dossier coverage.
Compound 61437 is a androgen modulator asset inside androgen modulator innovation track initiatives, optimized for endocrine support and performance longevity.
The dossier currently sits in post-market surveillance with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061437 with updates logged 2108-02-08.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Endocrine supportPerformance longevity
Nomenclature
CX-61437Androgen Modulator Program 61437
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061437
- [2] Operations Pulse • Androgen Modulator innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61437